The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Imatinib mesylate (Brand name: Gleevec®)
- Manufactured by
Novartis Pharmaceuticals Corp.
FDA-approved indication: Treatment of adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR (platelet-derived growth factor receptor)
National Library of Medicine Drug Information Portal